Answer : The major players in the GLP-1 market include Novo Nordisk, Eli Lilly and Company, Zealand Pharma, Structure Therapeutics, Amgen, Viking Therapeutics, Sanofi, AstraZeneca, and Hansoh Pharmaceutical Group Co
This month, the Central Drugs Standard Control Organization (CDSCO) has approved Ranibizumab for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Visual Impairment Due to Diabetic Macular Oedema (DME) As diabetes and age-related eye diseases continue to rise, innovations that help preserve vision are becoming more critical than ever
Beyond its role in fat metabolism, L-Carnitine also supports muscle function and helps regulate glucose metabolism, making it an essential nutrient for overall energy and metabolic health
Many women compare Josie vs Hers, both great GLP-1 programs for women in menopause
Weight changes after pregnancy are normal, expected, and not something that needs to be fixed with medication
Its GLP-1 program pairs FDA-approved treatments like Wegovy and Ozempic with coaching and nutrition advice